Why NOV Inc. (NOV) stock moved
NOV Inc. (NOV) shares rose 0.2% to $19.55 as of July 21, 2026, a slight gain from the prior close of $19.52. BestStocks flagged the session as a major change for NOV. Below, we break down what changed for NOV, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
NOV climbed 0.2% to $19.55
NOV moved +2.52% from $18.28 to $18.74 on 2026-07-08. Monitor next session.
What it means for NOV Inc. investors
For NOV Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.2% session move; NOV moved +2.52% from $18.28 to $18.74 on 2026-07-08. Weighing against that: NOV reported Q1 2026 earnings that missed estimates, with revenue of $2.05 billion down 2% year-over-year; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $20.88, implying +6.8% upside from $19.55. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 7 days out, the next report is the most likely near-term test of the move.
NOV price reaction
NOV last traded at $19.55, up $0.03 (+0.15%) from the previous close of $19.52. The session traded on 0.6× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $17.79 and $19.55, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on NOV Inc. (NOV)
The consensus analyst price target on NOV Inc. (NOV) is $20.88, 6.8% above the recent $19.55. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 1 downgrade. Here is how the bullish and bearish cases on NOV line up.
The bullish case
- Wall Street's consensus price target of $20.88 implies +6.8% upside from $19.55.
- The Street's most bullish target is $26.00 (+33.0%).
- Positive 0.2% session move.
- NOV moved +2.52% from $18.28 to $18.74 on 2026-07-08.
The bearish case
- The most bearish analyst target is $18.00 (-7.9%).
- 1 analyst downgrade in the past 90 days, most recently Barclays to Underweight (2026-05-08).
- NOV reported Q1 2026 earnings that missed estimates, with revenue of $2.05 billion down 2% year-over-year.
- NOV moved -1.28% from $18.02 to $17.79 on 2026-07-06.
- NOV Inc. (NOV) moved -0.44% from $18.10 to $18.02 on 2026-07-02.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for NOV
Frequently asked questions about NOV
Why did NOV Inc. (NOV) stock move?
NOV rose 0.2% to $19.55. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did NOV stock rise?
NOV gained 0.15% ($0.03) versus the prior close of $19.52, last trading at $19.55 on 0.6× average volume.
When is NOV Inc.'s next earnings date?
NOV's next earnings report is estimated for 2026-07-28 — about 7 days away.
What is the analyst price target for NOV?
The consensus analyst price target for NOV is $20.88, about 6.8% above the current $19.55. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 1 downgrade.
How BestStocks tracks NOV
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared NOV-specific materiality thresholds, triggering an evidence check. It draws on 8 tracked change events for NOV, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.